Changes in diabetes mortality in Sasovo district of Ryazan region during 2003—2013 years

Aim.

To study the overall mortality, mortality from cardiovascular diseases and cancer (CVD, C) in patients with diabetes mellitus (DM) in Sasovo District of Ryazan Region during 2003—2013 years.

Material and Methods.

We studied the diabetes overall mortality, CVD and cancer mortality dynamics in Sasovo District of Ryazan region during 2003—2013 years. In 2003, the population of the district was 52 100 people, in 2013 — 45 316. In 2003 years, it was registered 550 patients with diabetes, in 2013 years — 736.

The coefficients of overall mortality, mortality from diseases were calculated according to standard formulas per 1000 population.

Results.

It was revealed the reduction of total and cardiovascular mortality in the population (p<0,001) during period of observation. There is a trend towards reduction in total mortality and mortality from CVD in diabetic patients (p>0,05), but it is in 2—3,4 times higher than among the population The main causes of death in diabetic patients are CVD (67.8%) and cancer (10.9%), the dynamics of these figures were not observed.

Conclusions.

CVD and cancer are the leading cause of death in diabetes. Absence of changes in the level of CVD mortality, suggests the need for preventive measures for influence on this risk factor.

1. International Diabetes Federation. IDF Diabetes Atlas, 6th edition [2013]. Available on URL: http://www.idf.org/diabetesatlas.

2. Мировая статистика здравоохранения 2012 [доклад ВОЗ]. ВОЗ, 2013. [World healthcare statistic date. WHO, 2013. (in Russ.)]. Available from: http://apps.who.int/iris/bitstream/10665/44844/8/9789244564448_rus.pdf.

3. WHO. Dabetes mortality: age-standardized death rate per 100 000 population. 2000—2012. Available from: http://gamapserver.who.int/gho/interactive_charts/ncd/mortality/diabetes/atlas.html.

4. Hansen LJ, Olivarius Nde F, Siersma V. 16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study. BMC Public Health. 2009;9:400. doi: 10.1186/1471-2458-9-400.

5. Mulnier HE, Seaman HE, Raleigh VS, et al. Mortality in people with type 2 diabetes in the UK. Diabet Med. 2006;23(5):516-521. doi: 10.1111/j.1464-5491.2006.01838.x.

6. Балаболкин М.И. Фармакоэкономика сахарного диабета // Фарматека. – 2003. – №16. [Balabolkin MI. Pharmacoeconomics of the diabetes mellitus. Farmateca. 2003;(16). (In Russ.)].

7. Дедов И.И., Сунцов Ю.И., Кудрякова С.В., Рыжкова С.Г. О регистре сахарного диабета // Проблемы эндокринологии. – 1995. – Т. 41. - №3 - С. 4-7. [Dedov II, Suntsov YI, Kudryakova SV, Ryzhkova SG. O registre sakharnogo diabeta. Probl Endokrin (Mosk). 1995;(3):4-7. (In Russ.)].

8. Сунцов Ю.И., Дедов И.И., Кудрякова С.В. Государственный регистр сахарного диабета: эпидемиологическая характеристика инсулиннезависимого сахарного диабета // Сахарный диабет. – 1998. – Т.1. – №1 – С. 41-43. [Suntsov YI, Dedov II, Kudryakova SV. Gosudarstvennyy registr sakharnogo diabeta: epidemiologicheskaya kharakteristika insulinnezavisimogo sakharnogo diabeta. Diabetes mellitus. 1998;1(1):41-43. (In Russ.)] doi: 10.14341/2072-0351-6215.

9. Abduelkarem AR, El-Shareif HJ, Sharif SI. Prognostic indices for hospital mortality among Libyan diabetic patients. Practical Diabetes International. 2010;27(9):392-395a. doi: 10.1002/pdi.1528.

10. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulindependent diabetes. In: Harris MI. Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH. eds. Diabetes in America, 2nd ed. Washington, DC: National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 1995;233-257.

11. Hu FB, Stampfer MJ, Solomon CG, et al. The Impact of Diabetes Mellitus on Mortality From All Causes and Coronary Heart Disease in Women. Arch Intern Med. 2001;161(14):1717. doi: 10.1001/archinte.161.14.1717.

12. Mata-Cases M, De Prado-Lacueva C, Salido-Valencia V, et al. Incidence of complications and mortality in a type 2 diabetes patient cohort study followed up from diagnosis in a primary healthcare centre. Int J Clin Pract. 2011;65(3):299-307. doi: 10.1111/j.1742-1241.2010.02503.x.

13. Кудрякова С.В., Сунцов Ю.И. Некоторые данные регистра сахарного диабета // Проблемы эндокринологии. – 1994. – Т.40. - №1 - С. 4-6. [Kudryakova SV, Suntsov YI. Nekotorye dannye registra sakharnogo diabeta. Probl Endokrin (Mosk). 1994;40(1):4-6. (In Russ.)].

14. Комаров Ю.М. О значительных и грубых ошибках при использовании показателей здоровья и здравоохранения. [Интернет]. Главмединфо. 01.06.2012. [Komarov YM. About the significant and gross errors in the use of indicators of health and health care. [Internet]. Glavmedinfo. 01.06.12. (In Russ.)]. Available on URL: http://www.rmass.ru/publ/info/oshibki.

15. Рощин Д.О., Сабгайда Т.П., Евдокушина Г.Н. Проблема учета наличия сахарного диабета при диагностике причин смерти // Социальные аспекты здоровья населения. - 2012. - №5 – С. 4. [Roshchin DO, Sabgayda TP, Evdokushkina GN. The problem of diabetes mellitus recording while diagnostics of death causes. Sotsialnye aspekty zdorovya naseleniya. 2012;(5):4. (In Russ.)].

16. National Diabetes Audit Mortality Analysis 2007—2008. Key findings on mortality rates for people with diabetes in England. Report for the audit period 2007—2008. The NHS International Centre. 2011;40.

17. Ranc K, Jorgensen ME, Friis S, Carstensen B. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia. 2014;57(5):927-934. doi: 10.1007/s00125-014-3186-z.

18. Chiou W-K, Hwang J-S, Hsu K-H, Lin J-D. Diabetes Mellitus Increased Mortality Rates More in Gender-Specifi c than in Nongender-Specifi c Cancer Patients: A Retrospective Study of 149,491 Patients. Exp Diabetes Res. 2012;2012:1-6. doi: 10.1155/2012/701643.